Fidson Healthcare Plc (NGX: FIDSON)

Market Cap	39.47B
Revenue (ttm)	72.41B
Net Income (ttm)	3.48B
Shares Out	2.29B
EPS (ttm)	1.51
PE Ratio	11.37
Forward PE	n/a
Dividend	0.60 (3.49%)
Ex-Dividend Date	Jun 19, 2024

Volume	282,383
Average Volume	733,322
Open	n/a
Previous Close	17.20
Day's Range	n/a
52-Week Range	12.40 - 17.70
Beta	0.31
RSI	65.43
Earnings Date	Mar 28, 2025

About Fidson Healthcare

Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables. The company also provides products for anti infective and anti malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in 1995 and is based in Lagos,...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 650
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: FIDSON

Financial Performance

In 2023, Fidson Healthcare's revenue was 53.05 billion, an increase of 30.56% compared to the previous year's 40.63 billion. Earnings were 3.61 billion, a decrease of -13.84%.